Disinfecting agent comprising eugenol, terpineol and thymol
US-9132103-B2 · Sep 15, 2015 · US
US11497785B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11497785-B2 |
| Application number | US-201414917021-A |
| Country | US |
| Kind code | B2 |
| Filing date | Sep 5, 2014 |
| Priority date | Sep 6, 2013 |
| Publication date | Nov 15, 2022 |
| Grant date | Nov 15, 2022 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention relates to a composition for use as an oral anti-parasitic, the composition comprises one or more of an essential oil which contains gamma-terpinene, and/or carvacrol, and/or thymol, and/or terpinenol, and/or eucalyptol and/or eugenol, an essential oil of genus Cinnamomum, Eugenia, Eucalyptus or a source of saponin. It also relates to a method of preventing or treating parasitic infection in an animal, the method comprising orally administering to said animal a composition comprising one or more of an essential oil which contains gamma-terpinene, and/or carvacrol, and/or thymol, and/or terpinenol, and/or eucalyptol and/or eugenol, an essential oil of genus Cinnamomum, Eugenia, Eucalyptus or a source of saponin.
Opening claim text (preview).
The invention claimed is: 1. A pet consumable comprising a single oral anti-parasitic composition, the single oral anti-parasitic composition consisting of a source of saponin, an essential oil of oregano and an essential oil from genus Cinnamomum or from genus Eugenia , wherein the essential oil of oregano and the essential oil from genus Cinnamomum or Eugenia are present in the anti-parasitic composition in a ratio of from 4:1 to 1:4, and wherein the anti-parasitic composition exhibits a greater proliferation inhibition with respect to Neospora caninum or Toxoplasma gondii than the combined proliferation inhibition of the individual components. 2. The pet consumable of claim 1 , wherein the source of saponin contains a steroid sapogenin. 3. The pet consumable of claim 1 , wherein the consumable is a foodstuff, and wherein the foodstuff comprises 70% to 90% moisture. 4. The pet consumable of claim 1 , wherein the consumable is in the form of a liquid. 5. The pet consumable of claim 1 , wherein the consumable is a foodstuff, and wherein the foodstuff comprises 5% to 15% moisture. 6. The pet consumable of claim 5 , wherein the foodstuff comprises 10-40% protein or 5-40% fat. 7. The pet consumable of claim 6 , wherein the foodstuff is in the form of a biscuit. 8. The pet consumable of claim 5 , wherein the consumable is in the form of a tablet. 9. An anti-parasitic composition, consisting of an essential oil of oregano and an essential oil from genus Cinnamomum or genus Eugenia , and optionally, a source of saponin, wherein the essential oil of oregano and the essential oil from genus Cinnamomum or Eugenia are present in the anti-parasitic composition in a ratio of from 4:1 to 1:4, and wherein the anti-parasitic composition exhibits a greater proliferation inhibition with respect to Neospora caninum or Toxoplasma gondii than the combined proliferation inhibition of the individual components. 10. The pet consumable of claim 9 , wherein the single oral parasitic composition consists of an essential oil of oregano and an essential oil from genus Cinnamomum or genus Eugenia. 11. A method of preventing or treating parasitic infection in an animal, the method comprising orally administering to said animal an anti-parasitic composition consisting of a source of saponin, an essential oil of oregano and an essential oil from genus Cinnamomum , or from genus Eugenia , wherein the essential oil of oregano and the essential oil from genus Cinnamomum or Eugenia are present in the anti-parasitic composition in a ratio of from 4:1 to 1:4 and wherein the composition exhibits a greater proliferation inhibition with respect to Neospora caninum or Toxoplasma gondii than the combined proliferation inhibition of the individual components.
Myrtaceae (Myrtle family), e.g. teatree or eucalyptus · CPC title
Lauraceae (Laurel family), e.g. cinnamon or sassafras · CPC title
Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin · CPC title
Antiparasitic agents · CPC title
Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.